Whey Protein Lycosome Formulation Improves Vascular Functions and Plasma Lipids with Reduction of Markers of Inflammation and Oxidative Stress in Prehypertension

Table 3

Effect of markers of oxidative stress, inflammation, and NO.

Product	Chl.pn-IgG	CRP	LDL-Px	IOD	NO𝑥
	ELISA × 10^3	in 𝜇g/mL	ELISA × 10^3	in 𝜇M	in 𝜇M/L
WP baseline after 1 month (n = 10)	639 ± 55	8.0 ± 1.0	482 ± 53	97 ± 11	31 ± 6.3
	664 ± 62	7.4 ± 0.6	467 ± 62	94 ± 10	29 ± 5.5
	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05
Lycopene baseline after 1 month (n = 10)	842 ± 85	12.1 ± 1.7	461 ± 44	93 ± 11	26 ± 4.8
	754 ± 61	10.3 ± 1.6	413 ± 42	67 ± 9	30 ± 5.1
	P > 0.05	P > 0.05	P > 0.05	P < 0.05*	P > 0.05
WPL baseline after 1 month (n = 10)	725 ± 63	15.3 ± 2.2	410 ± 61	88 ± 9	23 ± 5.6
	342 ± 27	7.8 ± 1.5	295 ± 45	48 ± 5	38 ± 5.2
	P < 0.001*	P < 0.05*	P < 0.05*	P < 0.01*	P < 0.01*
Placebo baseline after 1 month (n = 10)	720 ± 81	7.2 ± 3.1	470 ± 43	86 ± 10	25 ± 4.4
	759 ± 79	7.4 ± 3.9	495 ± 61	85 ± 12	27 ± 4.1
	P > 0.05	P > 0.05	P > 0.05	P > 0.05	P > 0.05